Prospective Rates, Longitudinal Associations, and Factors Associated With Comorbid Insomnia Symptoms and Perceived Cognitive Impairment

Abstract

BackgroundInsomnia and cognitive impairment are both common conditions experienced by people diagnosed with cancer. Individually, these conditions have negative impacts on functioning, but the combined burden has yet to be evaluated. The purpose of this research was to estimate rates of comorbid insomnia and perceived cognitive impairments, examine the longitudinal associations between these two conditions, and identify demographic and clinical factors associated with reporting both insomnia and perceived cognitive impairment.MethodsIn this secondary analysis, a heterogeneous sample of 962 patients completed the Insomnia Severity Index (ISI) and the Cognitive Failures Questionnaire (CFQ) at the time of their cancer surgery (baseline; T1) and then again at 2 (T2), 6 (T3), 10 (T4), 14 (T5), and 18 (T6) months. Correlations and partial correlations, controlling for age and education level, were computed at each time point to assess the relationship between ISI and CFQ scores. Cross-lagged correlations assessed associations between ISI and CFQ scores over time. Proportions of patients with comorbid insomnia and cognitive impairments were calculated and logistic regressions investigated changes over time in these proportions. ANOVAs, logistic regressions, ordinal regressions, and multinomial regressions were used to identify risk factors of having comorbid insomnia and cognitive difficulties.ResultsSignificant and bidirectional correlations between ISI and CFQ scores were observed at each time point and over time. The proportion of patients having both clinical levels of insomnia and perceived cognitive difficulties ranged from 18.73 to 25.84% across time points and this proportion was significantly greater at T1 and T2 than T4, T5, and T6. Participants who reported comorbid insomnia and cognitive impairment were more likely to be younger, female, not currently working, currently receiving chemotherapy, with clinical levels depression and anxiety, and using antidepressants or anxiolytics.ConclusionComorbid insomnia and perceived cognitive impairment affects around one in five patients and is more frequent at the beginning of the cancer care trajectory. The relationship between insomnia and cognitive impairment appears to be bidirectional. Insomnia may represent an important patient level vulnerability that when identified and treated can improve perception of cognitive function.

Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients’ Real-World Insights for Optimizing Outcomes

“…Patient participants listed visuospatial awareness, decision-making skills, attention, processing speed, language, and memory as cognitive domains which should be assessed and incorporated into PCa-TRCI management, which are reinforced by previous literature and guidelines [ 47 , 57 ]. HCP participants clarified that a multitude of stressors, which are recognized in previous literature, may contribute to CI in patients with PCa and make assessment, diagnosis, and treatment difficult and complex [ 6 , 35 , 58 ]. These stressors should be assessed together for a more accurate clinical picture; however, there is no standardized definition or measure selection for CI, which may mean that its negative impact on patients is underestimated with at-risk patients unidentified [ 39 ].…”

Prevalence and factors associated with insomnia symptoms in adolescents and young adults with cancer during the COVID-19 pandemic

“…Insomnia is associated with increased risk of developing and worsened recovery from many mental health disorders in the general population. 35 Specifically in cancer survivors, insomnia is further associated with impaired quality of life, 36 problems with cognitive function, 37 and cancer-related fatigue. 38 Our results add to the growing recognition that the impact of cancer on AYAs does not end with the completion of treatment.…”

Randomized Controlled Trial of Virtually Delivered Cognitive Behavioral Therapy for Insomnia to Address Perceived Cancer-Related Cognitive Impairment in Cancer Survivors

“…Up to 60% of individuals with cancer report insomnia during or after cancer treatments, 13 and 26% will experience comorbid insomnia and CRCI. 14,15 Sleep disturbance is associated with the onset and persistence of cognitive issues after a cancer diagnosis. [16][17][18] Insomnia symptoms are also related to subjective and objective CRCI after diagnosis, 19 with evidence for a bidirectional relationship.…”